The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world data of systemic therapy for hepatocellular carcinoma in Japan: HERITAGE study.
 
Yoshinari Asaoka
Consulting or Advisory Role - Eisai
Speakers' Bureau - Abbvie; ASUKA Pharmaceutical; Chugai Pharma; Eisai; Gilead Sciences; Taisho Pharmaceutical Holdings
 
Ryosuke Tateishi
Honoraria - Abbvie; AstraZeneca; Bayer Yakuhin; Daiichi Sankyo; Eisai; Fujifilm; GE Healthcare; Gilead Sciences; Merck Sharp & Dohme; Otsuka; Shionogi; Sumitomo Dainippon
Consulting or Advisory Role - Bayer Yakuhin; Shionogi
Research Funding - Wako Diagnostics
 
Yasuhide Yamada
Honoraria - Boehringer Ingelheim; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst)
 
Hiroko Iijima
Speakers' Bureau - Otsuka
Research Funding - Abbvie (Inst); Canon Medical System (Inst); GE Healthcare (Inst); Otsuka (Inst); Sumitomo Dainippon Pharma (Inst)
 
Naoya Kato
Speakers' Bureau - Abbott; Abbvie; Aska Pharmaceutical Co., Ltd.; Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Bristol-Myers Squibb Company; Chugai Pharma; Covidien; Daiichi Sankyo Co.,Ltd.; EA Pharma; Eisai; Fujifilm; Gilead Sciences; Kowa; Lilly Japan; Mitsubishi Tanabe Pharma; Miyarisan pharmaceutical; Mochida Pharmaceutical Co. Ltd.; MSD K.K; Mylan; Nichi-iko; Nippon Kayaku; Nobelpharma; Olympus; Ono Pharmaceutical; Otsuka; Shionogi; Sumitomo Dainippon Pharma Co., Ltd.; Takeda; Tsumura & Co.; Zeria Pharmaceutical
Research Funding - Abbvie (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Aska Pharmaceutical Co.,Ltd. (Inst); Astellas Pharma (Inst); Boston Scientific (Inst); Chugai Pharma (Inst); Covidien (Inst); CYTLIMIC (Inst); Daiichi Sankyo co.,Ltd. (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); JIMRO (Inst); Kowa (Inst); Medicos Hirata (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD K.K. (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Shionogi (Inst); Sumitomo Dainippon Pharma Co.,Ltd. (Inst); Takeda (Inst); Tsumura & Co. (Inst)
 
Mitsuo Shimada
Speakers' Bureau - Chugai Pharma
Research Funding - Abbvie (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Eisai (Inst); Johnson & Johnson K.K. (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TSUMURA & CO. (Inst)
 
Etsuro Hatano
Honoraria - Abbvie; Bayer; Chugai Pharma; Eisai; Incyte; Lilly; Merck; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Novartis; Shionogi
Research Funding - Eisai; Tsumura & Co.
 
Takumi Fukumoto
Stock and Other Ownership Interests - Dream Fastener; PIHP Medical Co., Ltd.
Research Funding - Alfresa Pharma Corporation (Inst); Eisai (Inst); Japan Blood Products Organization (Inst); PorMedTec (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Alfresa Pharma Corporation (Inst)
 
Takamichi Murakami
Research Funding - Bayer (Inst); Eisai (Inst); GE Healthcare (Inst); Guerbet (Inst); Nihon Medi-Physics (Inst); Siemens Healthcare Diagnostics (Inst)
 
Hirohisa Yano
No Relationships to Disclose
 
Kengo Yoshimitsu
Speakers' Bureau - Bayer; Canon Medical System; Chugai Pharma; Eisai; Elekta; Fuji Pharma; Fujifilm; GE Healthcare; GE Healthcare; Siemens
 
Masayuki Kurosaki
Speakers' Bureau - Abbvie; Chugai Pharma; Eisai; Gilead Sciences; Janssen; Lilly Japan; Takeda
 
Michiie Sakamoto
Research Funding - CYTLIMIC (Inst); Eisai (Inst)
 
Yutaka Matsuyama
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Research Funding - Abbvie (Inst); Chugai/Roche; EA Pharma (Inst); Eisai (Inst); GE Healthcare; Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Norihiro Kokudo
No Relationships to Disclose